Replies to post #9182 on Momenta Pharmaceuticals, Inc. (MNTA)

[io_io]

Actually, until we see the final ruling for overturning the PI, we have no clue as to which side is ahead in the litigation.

So......ask youself, what is at the end of the rainbow here? I tried to explain it before, here (see also the replies) ->
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=68442959

Ask youself - but not the legal question, as obviously the "legal" advice on patents has not been very good on this and the BV board. Instead ask the moral question - who did the work behind what part of these approval projects, and how much, and I think you can see that the subject patent - a 'process' patent - is not much to talk about. Now of course morality is not law, but it is a 'fairness' guide to a starting point at which the parties might settle.

So, compared to biotechs where there is much to hope for in terms of paradigm shifts, etc - in this case, I see only a process patent surrounding a generic - really, very, very little.